Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus-Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center.

MLA

Tsai, C.Jillian, et al. “Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus-Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center.” Practical Radiation Oncology, vol. 9, no. 2, Mar. 2019, pp. 98–101. EBSCOhost, https://doi.org/10.1016/j.prro.2018.10.015.

APA

Tsai, C. J., McBride, S. M., Riaz, N., & Lee, N. Y. (2019). Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus-Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center. Practical Radiation Oncology, 9(2), 98–101. https://doi.org/10.1016/j.prro.2018.10.015

Chicago

Tsai, C Jillian, Sean M McBride, Nadeem Riaz, and Nancy Y Lee. 2019. “Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus-Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center.” Practical Radiation Oncology 9 (2): 98–101. doi:10.1016/j.prro.2018.10.015.